Medical Treatments: Innovation

(asked on 11th April 2016) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, whether the consultation on the database created by the Access to Medical Treatments (Innovation) Act 2016 will involve (a) medical research charities, (b) the pharmaceutical sector and (c) the Medicines and Healthcare Products Regulatory Agency.


Answered by
George Freeman Portrait
George Freeman
This question was answered on 18th April 2016

The Health and Social Care Information Centre will consult with stakeholders including charities, the relevant Royal Colleges, industry, the Medicines and Healthcare products Regulatory Agency and other relevant bodies in the creation of the Database described in the Act, when the power vested on the Secretary of State is enacted.

Reticulating Splines